Olink Holding
Olink Holding AB, commonly referred to as Olink, is a pioneering biotechnology company headquartered in Sweden. Founded in 2016, Olink has rapidly established itself as a leader in the field of proteomics, focusing on advanced biomarker discovery and development. The company operates primarily in Europe and North America, providing innovative solutions for researchers in the life sciences sector. Olink's core offerings include its proprietary Olink Explore and Olink Target platforms, which utilise unique proximity extension assay technology to deliver high-throughput protein analysis. This innovative approach sets Olink apart, enabling researchers to gain deeper insights into complex biological processes. With a strong market position, Olink has achieved significant milestones, including partnerships with leading academic institutions and pharmaceutical companies, solidifying its reputation as a key player in the biotechnology industry.
DitchCarbon Score
How does Olink Holding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Olink Holding's score of 39 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Olink Holding's reported carbon emissions
In 2021, Olink Holding, headquartered in Sweden, reported total carbon emissions of approximately 495,400 kg CO2e. This figure includes 3,950 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and a significant 448,400 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, Olink's Scope 3 emissions, which encompass all other indirect emissions in the value chain, amounted to about 43,100 kg CO2e. Olink Holding has made commitments towards reducing its carbon footprint, although specific reduction targets have not been established. The company has indicated a commitment to near-term climate action, but it has not set a net-zero target or long-term reduction goals. As part of the pharmaceuticals, biotechnology, and life sciences sector, Olink is positioned to contribute to broader industry efforts in addressing climate change, despite the absence of formalised reduction initiatives at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 3,950 |
| Scope 2 | 448,400 |
| Scope 3 | 43,100 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Olink Holding is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
